Home > Register for programs > Live Meetings    
Pharmacists Roadmap to Pain Management

Zero Tolerance for HAIs:
Pharmacists Take the Next Step

Outcomes Now Available

Herpes Zoster Vaccination: Clinical Update


Addressing Opioid Induced Constipation (OIC)

Pain Management Point of Care

OPAT Point of Care

Antifungal Stewardship
Point of Care


 Meeting the Challenges in HABP/VABP: A Time to Maximize Outcomes in Gram-Negative Resistance
 Marriott Marquis
901 Massachusetts Ave. NW
Washington, DC
Meeting Room: Independence Salon A-D, Level M4
 Wednesday, October 2, 2019
 6:00 PM  -  8:30 PM

Registration Faculty



Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) continue to place a substantial clinical and economic burden on healthcare systems despite prevention efforts. VABP is associated with high mortality that can range from 20% to 50%. Though HABP is considered less severe than VABP, serious complications occur in approximately half of these cases. Compounding the challenges of treating HABP/VABP is the prevalence of infections caused by multidrug-resistant (MDR) bacteria, including ESBL-producing and carbapenem-resistant Enterobacteriaceae and MDR P. aeruginosa. As the CDC and WHO have identified these Gram-negative pathogens as serious healthcare threats, Infectious Disease specialists must continue to spread awareness and implement strategies to minimize the burden of these infections that complement antimicrobial stewardship efforts.

Clinicians must be aware of the latest tools that can greatly enhance their ability to effectively identify and manage HABP/VABP caused by MDR gram-negative pathogens. These tools include rapid diagnostics that can accurately detect resistant pathogens as well as potent antimicrobial agents with novel modes of action that can overcome resistance mechanisms. ID clinicians must have a thorough understanding of the properties of the newer therapeutic options in order to optimally utilize therapeutics in a pathogen-specific manner when confronted with MDR pathogens.

This program is designed to build competence, confidence, and skills in the management of HABP/VABP while increasing the understanding of how to utilize the latest tools as part of antimicrobial stewardship efforts and interprofessional healthcare team.


This continuing medical education activity is planned to meet the needs of healthcare providers in a variety of practice settings, including large and small health systems, outpatient clinics, managed-care organizations, long-term care facilities, and academia. This activity would be especially beneficial for ID physicians and pharmacists who are on the frontline of managing patients with serious bacterial infections.


At the conclusion of the educational activity, the learner should be able to:
  • Discuss current epidemiological trends and resistance mechanisms of multidrug-resistant (MDR) Gram-negative bacteria
  • Differentiate between hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) when considering the burden, cause, and management approaches
  • Identify how to optimally utilize the available tools aimed at improving clinical outcomes of patients with HABP/VABP, including rapid diagnostic techniques and newer antimicrobial agents
  • Evaluate the benefits in utilizing a pathogen-specific approach when managing patients with HABP/VABP caused by MDR Gram-negative pathogens


Registration and Dinner: 6:00 6:30 PM
Educational Program: 6:30 8:30 PM
6:30 6:40 PM Welcome and Introduction
Patient Case Introduction
Keith Kaye, MD
6:40 7:00 PM Epidemiology and Mechanisms of MDR Gram-Negative Bacterial Infections
Keith Kaye, MD
7:00 7:20 PM Available Tools to Address Challenges of MDR
Gram-Negative Infections

George Karam, MD
7:20 7:45 PM Strategies in Managing HABP/VABP: A Review of the Clinical Evidence
Richard Wunderink, MD
7:45 8:05 PM Maximizing Outcomes in the Management of HABP/VABP
James Lewis, PharmD
8:05 8:15 PM Patient Case Conclusions
Led by James Lewis, PharmD
8:15 8:30 PM Learning by Sharing: Q and A


There is no fee to participate in this educational activity.


Accreditation This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Center for Independent Healthcare Education (Center) and Vemco MedEd. Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Center designates this live activity for a maximum of 2.0 AMA PRA Category 1
™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
AAPA accepts AMA PRA Category 1 Credit(s)™ for the PRA from organizations accredited by ACCME.

Nurse Practitioners
Nurse Practitioners will receive certificate of AMA PRA Category 1 Credit(s)™ as this is an ACCME accredited program and its accreditation is recognized by Nurse Practitioner boards.

Accreditation Center for Independent Healthcare Education is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education. Center has assigned 2.0 contact hours (0.2 CEUs) of continuing pharmacy education credits for participating in this activity.

ACPE UAN: 0473-9999-19-005-L01-P        Activity type: Application-based

For questions regarding accreditation, please contact


To receive a Certificate of Credit, participants must register for the symposium, document attendance, and complete and return the evaluation form.
Physicians: A Certificate of Credit will be emailed to you within 4 weeks after the symposium.
Pharmacists: Credit will be uploaded to CPE Monitor within 4 weeks after the symposium.


Center for Independent Healthcare Education and Vemco MedEd require faculty, planners, and others who are in a position to control the content of continuing education activities to disclose to the audience any real or apparent conflict of interest related to the activity. All identified conflicts of interest are reviewed and resolved to ensure fair balance, objectivity, and scientific rigor in all activities. The faculty is further required to disclose discussion of off-label uses in their presentations.


Vemco MedEd and Center for Independent Healthcare Education fully comply with the Americans With Disabilities Act. Please submit a written request at least 5 days prior to the meeting, and we will be glad to assist you with any special needs required to make this program accessible to you. Please email your request to idfocus@vemcomeded.com.

Jointly provided by
Center for Independent Healthcare Education and Vemco MedEd

Supported by an educational grant from Merck & Co., Inc.


Home | About Us | What We Do | CME Portal | Register for Programs | Outcomes Reports | Contact Us | Legal | Privacy Statement
© 2020 Vemco MedEd, LLC I All Rights Reserved.